A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Lawrence H. Kushi, ScD
Advertisement
Articles by Lawrence H. Kushi, ScD
Advertisement
Latest Updated Articles
- Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
Published: May 17th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC
3
Jury Still Out on Testosterone Benefit to Menopause
4
Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer
5
